Product Positioning for a Novel Cancer Therapy
ADVI assisted a client in Phase II development of a novel cancer therapy in preparing for launch, holding discussions with potential commercial payers and CMS.
ADVI assisted a client in Phase II development of a novel cancer therapy in preparing for launch, holding discussions with potential commercial payers and CMS. The ADVI team undertook a thorough analysis of the way that the product would likely be used in the clinic and hospital outpatient department, using both its SNAP Reimbursement tool and ADVI SAVEs 100 percent Medicare data files. This research included the product’s positioning relative to existing therapies and future therapies, physician reaction to the efficacy and side effect profile, as well as pricing and dosage regimen. Based on these insights, ADVI developed a launch roadmap, timeline for coding and reimbursement activities, a coverage strawman, a MAC advocacy plan, as well as a draft dossier for commercial payers.
CEO insights
Related articles
Real analysis from people who’ve been there
CMMI Engagement on CGT Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.